A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib

PURPOSE: Cyclosporine A (CsA) and imatinib are both CYP3A4 and P-glycoprotein substrates. Concomitant use after hematopoietic stem cell transplantation (HSCT) for chronic myeloid leukemia (CML) or Philadelphia chromosome-positive (Ph+) acute lymphatic leukemia (ALL) may therefore result in a pharmac...

Descripción completa

Detalles Bibliográficos
Autores principales: Atiq, Ferdows, Broers, Annoek E C, Andrews, Louise M, Doorduijn, Jeanette K, Koch, Birgit C P, Van Gelder, Teun, Versmissen, Jorie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Pharmacokinetics and Disposition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865545/
https://www.ncbi.nlm.nih.gov/pubmed/26965514
http://dx.doi.org/10.1007/s00228-016-2038-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865545/
https://www.ncbi.nlm.nih.gov/pubmed/26965514
http://dx.doi.org/10.1007/s00228-016-2038-9

Ejemplares similares